Abstract
The complex diseases, namely, Type 2 Diabetes Mellitus (T2DM) and Parkinson's Disease (PD), are extensively studied due to their prevalence in a large population group. Between these two diseases, T2DM is denoted as the zero index disease in a patient, which may lead to PD in a more advanced clinical stage. Both of these diseases may occur due to abrupt DNA methylation of genes. Likewise, both diseases may occur in a patient due to protein misfolding. Our study proposes a novel framework for building two disease-specific heterogeneous networks by integrating different tissue-based transcriptomics, epigenetics, epistasis, and PPI-based topological information. We predict the missing links between the DNA methylation and Post-Translational Modification (PTMs) associated with protein aggregation. Next, we have predicted the common signature of the prevalence of linked patterns in both diseases, further validated by relevant biological evidence.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
MsigDB - Pathway database GEO dataset - Gene expression and Methylation data GWAS - SNPs data GTEx - Tissue-specific datasets
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.